We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi/Regeneron’s Praluent Effective at Lowering Bad Cholesterol
Sanofi/Regeneron’s Praluent Effective at Lowering Bad Cholesterol
Sanofi and Regeneron’s biweekly injectable Praluent effectively lowers bad LDL cholesterol and has few side effects, the FDA says in briefing materials released ahead of a Tuesday advisory committee meeting.